Developing innovative, patient-and physician-friendly medications for serious
unmet medical needs

Summit Mission Statement

To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial enrollment, regulatory approval, and commercializing patient-, physician-, caregiver-, payor-, and societal-friendly medicinal therapy* intended to improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.  To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when and where appropriate. 

We accomplish this by building a team of world class scientists and business administrators that apply themselves to this mission.  Team Summit exists to strategize and execute a path forward in medicinal therapeutic health care that places us in a well-deserved top market share leadership position.  Team Summit assumes responsibility for stimulating continuous expansion of knowledge, ability, capability, and wealth for all involved stakeholders. 

*For our purposes, friendly medicinal therapy is defined as follows:  therapeutic efficacy (cure with duration and without recurrence and resistance) over therapeutic trauma.  Therapeutic trauma is defined as serious side effects while on therapy or post-therapy but related to therapy, disease recurrence, patient noncompliance with daily dosage due to challenges associated with our therapy, its unaffordability, or inaccessibility. 

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK, Cambridge, UK, and Menlo Park, California.